Adverse Events
View by Disease/Vaccine

Immunizations are a cornerstone of the nation's efforts to protect people from a host of infectious diseases and are held to the highest standards of safety. The United States currently has the safest, most effective vaccine supply in history. Years of testing are required by law before a vaccine can be licensed. Once in use, vaccines are continually monitored for safety and effectiveness.

Like all medicines, there are side effects, or "adverse effects," associated with some vaccines, though they are generally rare or minor. Vaccines have mild side effects, such as pain, tenderness, or redness at the site of injection; and some have rare, but more serious, side effects. Anything that we put into our bodies (like vitamins or antibiotics) can have side effects, nothing is harmless. As health care workers it is our job to address the many myths and misinformation about vaccine safety that can confuse individuals who are trying to make sound health care decisions.

Understanding the proper treatment for a vaccine adverse reaction, procedures for reporting adverse events, and addressing the concerns of our beneficiaries is critical in providing excellent immunization healthcare.

Did You Receive the Anthrax Vaccine While Pregnant?
U.S. Department of Health and Human Services; Health Resources and Services Administration
U.S. Department of Health and Human Services; Centers for Disease Control and Prevention and Food and Drug Administration
Did You Receive the Smallpox Vaccine While Pregnant?
U.S. Department of Health and Human Services; Health Resources and Services
Centers for Disease Control and Prevention - Abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP)
Safety Review PDF 01 Jan 12
Detailed Safety Review of Anthrax Vaccine Adsorbed
Vaccine Healthcare Center
For specialized immunization consultation and care.
Recommendations of the Armed Forces Epidemiological Board (AFEB)
U.S. Department of Health and Human Services; Health Resources and Services Administration, Countermeasures Injury Compensation Program
U.S. Department of Health and Human Services; Health Resources and Services Administration, Countermeasures Injury Compensation Program
VAERS 09 Jan 06
Vaccine Adverse Event Reporting System
U.S. Department of Health and Human Services; Health Resources and Services Administration
U.S. Department of Health and Human Services; Health Resources and Services Administration
Vaccine Safety 26 Apr 13
Immunization Action Coalition
Centers for Disease Control and Prevention
Vaccines, Blood & Biologics; Food and Drug Administration
For specialized immunization consultation and care.
VAERS 09 Jan 06
Vaccine Adverse Event Reporting System
Immunization Action Coalition
Centers for Disease Control and Prevention - Abstracted from recommendations of the Advisory Committee on Immunization Practices (ACIP)
Did You Receive the Anthrax Vaccine While Pregnant?
Vaccine Healthcare Centers Network (VHC)
Safety Review PDF 01 Jan 12
Detailed Safety Review of Anthrax Vaccine Adsorbed
EpiPen® and EpiPen Jr® Auto-Injectors (0.3 and 0.15 mg epinephrine) are for the emergency treatment of severe allergic reactions (anaphylaxis) caused by allergens, exercise, or unknown triggers; and for patients who are at increased risk for these reactions.
Vaccine Healthcare Centers Network
Latex-free Stopper Information Letter
Safety Review PDF 01 Jan 12
Detailed Safety Review of Anthrax Vaccine Adsorbed
Latex-free Stopper Information Letter
Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA)
Overview and purpose of the Countermeasures Injury Compensation Program.
The U.S. Department of Health and Human Services is the payer of last resort, which means CICP covers what remains unpaid or unpayable by other third parties, e.g., health insurance.
EpiPen® and EpiPen Jr® Auto-Injectors (0.3 and 0.15 mg epinephrine) are for the emergency treatment of severe allergic reactions (anaphylaxis) caused by allergens, exercise, or unknown triggers; and for patients who are at increased risk for these reactions.
Video: An Overview of VAERSAn Overview of VAERS (10:37) 01 Mar 11
This 10-minute video describes the Vaccine Adverse Event Reporting System (VAERS)
Author(s): Niu MT, Ball R, Woo EJ, Burwen DR, Knippen M, Braun MM, The VAERS Working Group
Publication: Vaccine 27 (2009) 290-297
Subject: Vaccine-Safety
Disease: 
Anthrax
Category: 
Adverse Events
Author(s): Wasserman GM, Grabenstein JD, Pittman PR, Rubertone MV, Gibbs PP, Wang LZ, Golder LG
Publication: JOEM Volume 45, Number 3
Subject: Vaccine-Safety
Disease: 
Anthrax
Category: 
Adverse Events
Author(s): Centers for Disease Control and Prevention
Publication: Morbidity & Mortality Weekly Report (MMWR) 2000;49(Apr 28):341-5. [reprinted in JAMA 2000;283(May 24/31):2648-9]
Subject: Vaccine-Safety
Disease: 
Anthrax
Category: 
Adverse Events
Author(s): Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, West DJ
Publication: Pharmacoepidemiology and Drug Safety
Subject: Vaccine-Safety
Disease: 
Anthrax
Category: 
Adverse Events